Global RNA Microarray Market to Reach USD 2.52 Billion by 2030 at 9.3% CAGR, Driven by Precision Medicine and AI-Driven Analysis

RNA microarray market grows from USD 1.77 Billion in 2026 to USD 2.52 Billion by 2030, driven by precision medicine, cancer research, AI-driven gene expression analysis and cloud bioinformatics.Dublin ...

Microarray Scanners - Global Strategic Business Report 2026: Capitalize on $1.6 Billion Industry Revenue by 2032 | Thermo Fisher Scientific, Agilent Technologies, Illumina, and ...

Dublin, Oct. 28, 2026 (GLOBE NEWSWIRE) -- "Microarray Scanners - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global microarray scanners market was valued ...
BIOENGINEER

Transcriptomic Analysis Identifies Candidate Hub Genes and Immune Signatures in Insomnia

An integrative transcriptomic and immune-genomic study of peripheral blood has identified SPTLC1, PTGES3, and HLA-G as ...
Medical Xpress

New AI tool could replace costly cancer gene expression profiling

A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes expressed in cancerous tumors. The AI-based tool, which they describe in ...
ascopubs.org

RNA-Seq based gene expression profiling of baseline and on-treatment breast tumors to predict response to HER2-directed therapy, without chemotherapy (TBCRC026).

Breast Cancer Index re-stratifies 21-gene assay risk groups for late distant recurrence and extended endocrine therapy benefit: Results from the BCI Registry Study. This is an ASCO Meeting Abstract ...